These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20406174)

  • 1. Monoclonal antibodies in solid tumours.
    Markman B; Tabernero J
    Curr Clin Pharmacol; 2010 Aug; 5(3):160-5. PubMed ID: 20406174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of monoclonal antibodies as cancer therapy in solid tumors.
    Dienstmann R; Markman B; Tabernero J
    Curr Clin Pharmacol; 2012 May; 7(2):137-45. PubMed ID: 22432839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors.
    Argyriou AA; Kalofonos HP
    Mol Med; 2009; 15(5-6):183-91. PubMed ID: 19305491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.
    Gialeli Ch; Kletsas D; Mavroudis D; Kalofonos HP; Tzanakakis GN; Karamanos NK
    Curr Med Chem; 2009; 16(29):3797-804. PubMed ID: 19747140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular target therapy for colonic neoplasms].
    Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions.
    Starling N; Cunningham D
    Curr Opin Oncol; 2004 Jul; 16(4):385-90. PubMed ID: 15187895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.
    Capdevila J; Elez E; Macarulla T; Ramos FJ; Ruiz-Echarri M; Tabernero J
    Cancer Treat Rev; 2009 Jun; 35(4):354-63. PubMed ID: 19269105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors.
    Caponigro F; Formato R; Caraglia M; Normanno N; Iaffaioli RV
    Curr Opin Oncol; 2005 May; 17(3):212-7. PubMed ID: 15818163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the treatment of advanced colorectal cancer.
    Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with monoclonal antibodies to epidermal growth factor receptor.
    Calvo E; Rowinsky EK
    Curr Oncol Rep; 2005 Mar; 7(2):96-103. PubMed ID: 15717942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New developments in immunotherapy for digestive system diseases].
    Imai K
    Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1901-7. PubMed ID: 16223155
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidermal growth factor inhibition in solid tumours.
    Ganti AK; Potti A
    Expert Opin Biol Ther; 2005 Sep; 5(9):1165-74. PubMed ID: 16120047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic antibodies.
    Groner B; Hartmann C; Wels W
    Curr Mol Med; 2004 Aug; 4(5):539-47. PubMed ID: 15267225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives.
    Roviello G; Polom K; Petrioli R; Marano L; Marrelli D; Paganini G; Savelli V; Generali D; De Franco L; Ravelli A; Roviello F
    Tumour Biol; 2016 Jan; 37(1):127-40. PubMed ID: 26566626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB antagonists patenting: "playing chess with cancer".
    Aifa S; Rebai A
    Recent Pat Biotechnol; 2008; 2(3):181-7. PubMed ID: 19075865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patients.
    Jackson C; Cunningham D
    Clin Colorectal Cancer; 2007 Dec; 7 Suppl 1():S8-15. PubMed ID: 18361806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The potential of monoclonal antibodies in cancer : established trastuzumab and cetuximab and promising targets IGF-1R and c-MET].
    Bodmer A; Goetsch L; Favet L; Bailly C; Corvaia N; Dietrich PY
    Med Sci (Paris); 2009 Dec; 25(12):1090-8. PubMed ID: 20035684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies as effective therapeutic agents for solid tumors.
    Hinoda Y; Sasaki S; Ishida T; Imai K
    Cancer Sci; 2004 Aug; 95(8):621-5. PubMed ID: 15298722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EGFR as a target for anticancer therapy--focus on cetuximab.
    Baselga J
    Eur J Cancer; 2001 Sep; 37 Suppl 4():S16-22. PubMed ID: 11597400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies in the treatment of colorectal cancers.
    Alekshun T; Garrett C
    Cancer Control; 2005 Apr; 12(2):105-10. PubMed ID: 15855893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.